TIAA CREF Investment Management LLC decreased its position in shares of Davita Inc (NYSE:DVA) by 11.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 516,072 shares of the company’s stock after selling 68,752 shares during the quarter. TIAA CREF Investment Management LLC’s holdings in Davita were worth $37,286,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of DVA. Schroder Investment Management Group grew its position in shares of Davita by 769.0% during the 3rd quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock worth $25,387,000 after buying an additional 384,224 shares in the last quarter. Accident Compensation Corp grew its position in shares of Davita by 106.3% during the 3rd quarter. Accident Compensation Corp now owns 31,150 shares of the company’s stock worth $1,850,000 after buying an additional 16,050 shares in the last quarter. California Public Employees Retirement System grew its position in shares of Davita by 1.9% during the 3rd quarter. California Public Employees Retirement System now owns 490,132 shares of the company’s stock worth $29,109,000 after buying an additional 9,332 shares in the last quarter. Hikari Power Ltd grew its position in shares of Davita by 6.9% during the 4th quarter. Hikari Power Ltd now owns 333,920 shares of the company’s stock worth $24,126,000 after buying an additional 21,620 shares in the last quarter. Finally, Country Club Trust Company n.a. bought a new position in shares of Davita during the 4th quarter worth $207,000. 85.79% of the stock is currently owned by institutional investors and hedge funds.
Shares of DVA stock opened at $65.00 on Friday. The company has a debt-to-equity ratio of 1.87, a quick ratio of 2.82 and a current ratio of 2.88. The firm has a market capitalization of $11,973.78, a price-to-earnings ratio of 18.90, a P/E/G ratio of 0.95 and a beta of 1.03. Davita Inc has a 12 month low of $52.51 and a 12 month high of $80.71.
Davita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.02). The company had revenue of $2.78 billion for the quarter, compared to analysts’ expectations of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same quarter last year, the company earned $0.98 earnings per share. analysts anticipate that Davita Inc will post 4.15 earnings per share for the current fiscal year.
A number of equities analysts have recently issued reports on the company. Bank of America reissued a “buy” rating and set a $92.00 price target (up previously from $85.00) on shares of Davita in a research report on Thursday, January 11th. JPMorgan Chase & Co. increased their price target on Davita from $4.90 to $84.00 and gave the stock a “strong-buy” rating in a research report on Thursday, December 7th. SunTrust Banks set a $70.00 price target on Davita and gave the stock a “hold” rating in a research report on Thursday, December 7th. KeyCorp reissued a “hold” rating on shares of Davita in a research report on Wednesday, December 6th. Finally, Robert W. Baird raised Davita from a “neutral” rating to an “outperform” rating and increased their price target for the stock from $63.00 to $82.00 in a research report on Tuesday, December 12th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating, four have assigned a buy rating and two have given a strong buy rating to the company’s stock. Davita currently has an average rating of “Hold” and a consensus price target of $79.30.
In related news, insider James K. Hilger sold 3,572 shares of the company’s stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $78.95, for a total transaction of $282,009.40. Following the completion of the sale, the insider now directly owns 33,649 shares in the company, valued at approximately $2,656,588.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.10% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Davita Inc (DVA) Shares Sold by TIAA CREF Investment Management LLC” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/03/24/davita-inc-dva-shares-sold-by-tiaa-cref-investment-management-llc.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.